ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
CAR-T
1,473.43
-7.1411
-0.48%
涨家数:
- -
跌家数:
2
平家数:
- -
市盈率:
- -
高:
1,482.72
开:
1,477.65
低:
1,468.28
收:
1,480.62
成交量:
280.78万
成交额:
3.21亿
市值:
3,831.32亿
流通市值:
3,712.66亿
数据加载中...
总览
新闻
诺华公司的 LEQVIO(英克西兰)在低密度脂蛋白胆固醇(LDL-C即 “坏胆固醇”)早期达标方面展现出具有统计学显著性
智通财经
·
08/30
惠誉计划撤销诺华制药(NVS.US)的评级。
格隆汇
·
08/27
吉利德(GILD.US)突破性长效HIV疗法在欧盟获批上市
智通财经
·
08/27
美股周二早盘吉利德科学(GILD)股价上涨0.5%该公司旗下HIV暴露前预防疗法来那帕韦钠注射液(lenacapavir
智通财经
·
08/26
吉利德科学公司(Gilead Sciences)周二表示该公司生产的用于预防艾滋病感染的一年两次注射剂已获得欧盟执委会的
智通财经
·
08/26
欧盟批准吉利德公司用于预防艾滋病的新型注射剂
路透中文
·
08/26
吉利德科学子公司以3.5亿美元收购Interius BioTherapeutics
格隆汇
·
08/21
吉利德公司将以 3.5 亿美元收购细胞疗法开发商 Interius
路透中文
·
08/21
美股异动|吉利德科学跌超3% CVS暂缓将其艾滋病预防新药纳入医保名单
格隆汇
·
08/21
Kite:与Interius的交易预计将使吉利德科学2025年GAAP和非GAAP每股收益减少约0.23-0.25美元
美股速递
·
08/21
吉利德科学盘前跌2.9% 因CVS暂缓将其新型HIV预防针剂纳入药物保险覆盖清单
美股速递
·
08/21
8月20日诺华集团宣布创新产品诺锐达(盐酸阿曲生坦片)获得国家药品监督管理局批准用于降低有疾病快速进展风险的原发性免疫球
智通财经
·
08/20
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4578/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1473.4825,"timestamp":1756839560815,"preClose":1480.6237,"halted":0,"volume":2808309,"delay":0,"changeRate":-0.004823,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-7.141113,"latestTime":"09-02 14:59:21 EDT","open":1477.6458,"high":1482.7235,"low":1468.2784,"amount":321126521.926554,"amplitude":0.009756,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1756843200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.224867,"peRate":19.224596,"turnoverRate":0.000911,"increases":0,"decrements":2,"flats":0,"marketCap":383132024832,"floatMarketCap":371266387968},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1482.7235,"amplitude":0.009756,"preClose":1480.6237,"low":1468.2784,"pbRate":"6.224867","latestPrice":1473.4348,"volume":2807805,"delay":0,"open":1477.6458,"prevYearClose":1164.883,"prevWeekClose":1480.6237,"prevMonthClose":1480.6237,"prevQuarterClose":1430.2296,"fiveDayClose":1475.2361,"twentyDayClose":1423.5317,"sixtyDayClose":1403.9991,"secType":"PLATE","market":"US","turnoverRate":0.000911,"peRate":19.224596,"marketCap":383132024832,"floatMarketCap":371266387968,"timestamp":1756839555506,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":0,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2563889540","title":"诺华公司的 LEQVIO(英克西兰)在低密度脂蛋白胆固醇(LDL-C即 “坏胆固醇”)早期达标方面展现出具有统计学显著性","url":"https://stock-news.laohu8.com/highlight/detail?id=2563889540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563889540?lang=zh_cn&edition=fundamental","pubTime":"2025-08-30 23:02","pubTimestamp":1756566124,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4585","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0208291251.USD","IE0009355771.USD","BK4578","LU0070302665.USD","BK4532","BK4007","LDL","LU0211331839.USD","LU0320765489.SGD","IE00B2B36J28.USD","NVS","BK4588","IE0002141913.USD"],"gpt_icon":0},{"id":"2562473137","title":"惠誉计划撤销诺华制药(NVS.US)的评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2562473137","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562473137?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 22:12","pubTimestamp":1756303950,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0211331839.USD","BK1574","BK4585","BK4532","NVS","01477","IE00B4R5TH58.HKD","BK1191","BK4588","IE0009355771.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0208291251.USD","IE00BFTCPJ56.SGD","BK4007","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0070302665.USD","BK4578","LU0320765489.SGD"],"gpt_icon":0},{"id":"2562766434","title":"吉利德(GILD.US)突破性长效HIV疗法在欧盟获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2562766434","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562766434?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 07:41","pubTimestamp":1756251669,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","FESXmain","LU1430594728.SGD","LU1674673428.USD","BK4156","EC","IE00BKVL7J92.USD","LU0289739699.SGD","BK4201","LU1839511570.USD","IE00B3T34201.USD","BK4566","BK4568","BK4578","LU0109394709.USD","BK4585","IE00B7SZLL34.SGD","LU2468319806.SGD","SG9999015978.USD","BK4588","LU1778281490.HKD","LU1585245621.USD","SG9999015952.SGD","BK4550","LU0234570918.USD","LU1066053197.SGD","LU2087621335.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","GILD","FSXEmain","LU0320765992.SGD","LU1571399168.USD","LU0889565916.HKD","SG9999015986.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU2324357040.USD","LU0058720904.USD","LU1674673691.USD","LU0823416689.USD","EU","SG9999015945.SGD","LU1066051498.USD","BK4583","BK4139","IE00BSNM7G36.USD","IE0002270589.USD"],"gpt_icon":0},{"id":"2562730258","title":"美股周二早盘吉利德科学(GILD)股价上涨0.5%该公司旗下HIV暴露前预防疗法来那帕韦钠注射液(lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=2562730258","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562730258?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 23:05","pubTimestamp":1756220711,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4566","FSXEmain","LU1674673428.USD","LU1571399168.USD","IE0002270589.USD","FESXmain","IE00BZ1G4Q59.USD","LU0320765992.SGD","BK4139","SG9999015978.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU1839511570.USD","BK4585","BK4588","LU1066051498.USD","BK4583","LU1778281490.HKD","SG9999015952.SGD","BK4578","LU2324357040.USD","LU0889565916.HKD","LU1066053197.SGD","LU1585245621.USD","IE00BKVL7J92.USD","LU0058720904.USD","SG9999015986.USD","LU0109394709.USD","LU2468319806.SGD","BK4532","SG9999015945.SGD","BK4568","IE00B3T34201.USD","LU2087621335.USD","GILD","LU2089984988.USD","IE00B7SZLL34.SGD","LU0234570918.USD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU0823416689.USD","LU1674673691.USD","BK4550","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2562200298","title":"吉利德科学公司(Gilead Sciences)周二表示该公司生产的用于预防艾滋病感染的一年两次注射剂已获得欧盟执委会的","url":"https://stock-news.laohu8.com/highlight/detail?id=2562200298","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562200298?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 15:10","pubTimestamp":1756192224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0889565916.HKD","BK4566","IE00B19Z3B42.SGD","LU0109394709.USD","LU2087621335.USD","SG9999015986.USD","BK4550","FESXmain","LU1066053197.SGD","LU0320765992.SGD","LU0289739699.SGD","IE00B3T34201.USD","LU0058720904.USD","LU1778281490.HKD","GILD","LU0234570918.USD","LU1571399168.USD","BK4139","LU2468319806.SGD","LU2324357040.USD","IE0002270589.USD","LU1674673691.USD","FSXEmain","BK4568","LU1839511570.USD","BK4578","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU0823416689.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","SG9999015945.SGD","IE00BZ1G4Q59.USD","LU1066051498.USD","BK4585","BK4583","LU1585245621.USD","BK4532","LU1674673428.USD","SG9999015978.USD","BK4588","LU2089984988.USD","IE00BSNM7G36.USD","SG9999015952.SGD"],"gpt_icon":0},{"id":"2562200618","title":"欧盟批准吉利德公司用于预防艾滋病的新型注射剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2562200618","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562200618?lang=zh_cn&edition=fundamental","pubTime":"2025-08-26 15:00","pubTimestamp":1756191608,"startTime":"0","endTime":"0","summary":"欧盟批准吉利德公司用于预防艾滋病的新型注射剂欧盟、挪威、冰岛和列支敦士登批准来那卡巴韦用于 PrEP定价和报销将由各国决定吉利德公司的来那卡韦在试验中几乎100%有效Deena Beasley. 路透8月26日 - 吉利德科学公司周二表示,该公司生产的用于预防艾滋病感染的一年两次注射剂GILD.O已获得欧盟执委会的上市许可。欧盟执委会批准将这种药物用于暴露前预防,以降低感染致命病毒风险较高的成人和青少年通过性途径感染艾滋病毒的风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nL4T3UI0GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2324357040.USD","BK4532","LU0234570918.USD","SG9999015986.USD","LU0320765992.SGD","LU1674673691.USD","BK4583","LU1430594728.SGD","LU1571399168.USD","BK4550","SG9999015945.SGD","LU1585245621.USD","GILD","LU2468319806.SGD","LU1066053197.SGD","BK4578","IE00B7SZLL34.SGD","IE0002270589.USD","IE00BKVL7J92.USD","LU2089984988.USD","IE00BSNM7G36.USD","IE00B19Z3581.USD","LU0109394709.USD","LU1066051498.USD","LU0289739699.SGD","LU0823416689.USD","IE00B3T34201.USD","SG9999015952.SGD","LU1839511570.USD","LU0058720904.USD","SG9999015978.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1674673428.USD","BK4139","BK4566","LU1778281490.HKD","BK4585","LU2087621335.USD","LU0889565916.HKD","BK4568"],"gpt_icon":0},{"id":"2561549137","title":"吉利德科学子公司以3.5亿美元收购Interius BioTherapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2561549137","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561549137?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 23:00","pubTimestamp":1755788430,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4550","LU0058720904.USD","LU0823416689.USD","LU1778281490.HKD","LU1066053197.SGD","BK4230","SG9999015945.SGD","LU2087621335.USD","CAR","IE00B7SZLL34.SGD","BK4588","BK4585","IE00BKVL7J92.USD","LU0320765992.SGD","SG9999015986.USD","LU1585245621.USD","BK4578","LU0109394709.USD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU1674673691.USD","LU1839511570.USD","BK4532","BK4022","LU0289739699.SGD","SG9999015952.SGD","IE00B3T34201.USD","GILD","LU0234570918.USD","LU1066051498.USD","LU1674673428.USD","LU0889565916.HKD","SG9999015978.USD","IE0002270589.USD","LU2324357040.USD","BK4566","IE00B19Z3B42.SGD","BK4568","LU1430594728.SGD","BK4583","LU2468319806.SGD","IE00B19Z3581.USD","LU2089984988.USD","BK4139"],"gpt_icon":0},{"id":"2561496416","title":"吉利德公司将以 3.5 亿美元收购细胞疗法开发商 Interius","url":"https://stock-news.laohu8.com/highlight/detail?id=2561496416","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561496416?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 22:17","pubTimestamp":1755785858,"startTime":"0","endTime":"0","summary":"吉利德公司将以 3.5 亿美元收购细胞疗法开发商 Interius路透8月21日 - 吉利德科学 公司GILD.O旗下的 KitePharma 周四表示,它将以3.5亿美元现金收购私人控股的生物技术公司Interius BioTherapeutics,以推进CAR T细胞癌症 疗法的发展,这种疗法可直接输送到患者体内。为何重要该公司表示,此次收购将使 Kite 公司能够利用 Interius 的平台直接为 患者提供细胞疗法,从而简化治疗流程并降低成本。下一步计划吉利德公司补充说,交易获得批准后,Interius 的业务将与 Kite 在费城的研究团队合并。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nL4S3UD10J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","SG9999015945.SGD","BK4550","BK4578","LU1585245621.USD","SG9999015978.USD","LU1839511570.USD","IE00B3T34201.USD","BK4568","LU1778281490.HKD","IE00B7SZLL34.SGD","LU0320765992.SGD","LU2087621335.USD","BK4566","BK4583","LU1430594728.SGD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU0289739699.SGD","LU0823416689.USD","LU1674673428.USD","IE00BZ1G4Q59.USD","LU2468319806.SGD","SG9999015986.USD","LU2089984988.USD","LU1066053197.SGD","LU2324357040.USD","IE00B19Z3581.USD","LU1066051498.USD","BK4585","BK4588","IE0002270589.USD","LU1674673691.USD","LU0234570918.USD","IE00BSNM7G36.USD","LU1571399168.USD","IE00BKVL7J92.USD","LU0109394709.USD","BK4532","BK4139","SG9999015952.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2561498552","title":"美股异动|吉利德科学跌超3% CVS暂缓将其艾滋病预防新药纳入医保名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2561498552","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561498552?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 20:49","pubTimestamp":1755780567,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0061475181.USD","SG9999015945.SGD","BK4568","LU0234570918.USD","LU1674673691.USD","LU2087621335.USD","LU1066051498.USD","LU0208291251.USD","LU1778281490.HKD","LU2324357040.USD","BK4504","BK4585","IE00BKVL7J92.USD","IE00BSNM7G36.USD","SG9999015952.SGD","LU0070302665.USD","LU1699723380.USD","GILD","LU0823416689.USD","LU0211331839.USD","LU0320765489.SGD","LU0006061336.USD","LU1059921491.USD","BK4581","CVS","LU1571399168.USD","LU1066053197.SGD","LU1585245621.USD","LU1839511570.USD","LU2468319806.SGD","LU0289739699.SGD","LU0889565916.HKD","BK4588","IE00B7SZLL34.SGD","LU1674673428.USD","SG9999015978.USD","LU2089984988.USD","BK4583","IE0002270589.USD","BK4532","SG9999015986.USD","IE00B19Z3B42.SGD","IE00B3T34201.USD","BK4566","BK4139","LU0162691827.USD","LU1430594728.SGD","LU0109394709.USD","BK4578","BK4196"],"gpt_icon":0},{"id":"1141709744","title":"Kite:与Interius的交易预计将使吉利德科学2025年GAAP和非GAAP每股收益减少约0.23-0.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141709744","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141709744?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 20:31","pubTimestamp":1755779491,"startTime":"0","endTime":"0","summary":"Kite公司表示,与Interius的交易预计将使吉利德科学2025年的GAAP和非GAAP每股收益减少约0.23-0.25美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","LU0889565916.HKD","SG9999015952.SGD","LU1585245621.USD","IE00B3T34201.USD","SG9999015978.USD","LU2468319806.SGD","BK4568","BK4550","LU1674673428.USD","LU1674673691.USD","LU0234570918.USD","IE00BSNM7G36.USD","IE0002270589.USD","LU0320765992.SGD","BK4585","LU2087621335.USD","BK4583","IE00B7SZLL34.SGD","GILD","LU0823416689.USD","LU1430594728.SGD","LU1571399168.USD","BK4578","LU0289739699.SGD","LU2324357040.USD","LU0109394709.USD","LU1066051498.USD","BK4566","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU2089984988.USD","SG9999015986.USD","BK4588","LU0058720904.USD","LU1778281490.HKD","BK4532","LU1839511570.USD","BK4139"],"gpt_icon":0},{"id":"1144782410","title":"吉利德科学盘前跌2.9% 因CVS暂缓将其新型HIV预防针剂纳入药物保险覆盖清单","url":"https://stock-news.laohu8.com/highlight/detail?id=1144782410","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144782410?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 19:42","pubTimestamp":1755776534,"startTime":"0","endTime":"0","summary":"吉利德科学股价在盘前交易中下跌2.9%,此前有报道称CVS暂缓将该公司新型HIV预防针剂添加到药物保险覆盖清单中。这一消息对投资者情绪造成了影响,导致该生物技术公司股价在正式开盘前出现下滑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","IE00B7SZLL34.SGD","LU1839511570.USD","BK4585","BK4583","LU1778281490.HKD","LU0234570918.USD","LU1066051498.USD","LU1674673691.USD","LU0889565916.HKD","IE00BSNM7G36.USD","SG9999015945.SGD","BK4588","IE00B19Z3581.USD","BK4578","BK4139","LU0320765992.SGD","IE0002270589.USD","BK4566","BK4532","LU2089984988.USD","BK4568","LU0289739699.SGD","LU1430594728.SGD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU2087621335.USD","BK4550","GILD","SG9999015986.USD","LU1674673428.USD","LU2468319806.SGD","LU1571399168.USD","LU1585245621.USD","SG9999015978.USD","IE00B19Z3B42.SGD","LU0823416689.USD","SG9999015952.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2560124596","title":"8月20日诺华集团宣布创新产品诺锐达(盐酸阿曲生坦片)获得国家药品监督管理局批准用于降低有疾病快速进展风险的原发性免疫球","url":"https://stock-news.laohu8.com/highlight/detail?id=2560124596","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560124596?lang=zh_cn&edition=fundamental","pubTime":"2025-08-20 14:25","pubTimestamp":1755671107,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0070302665.USD","IE0002141913.USD","LU0208291251.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4578","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","NVS","BK4007","BK4532","BK4585","LU0211331839.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","IE0009355771.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}